Zhongyi Xu

16PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsAutoimmunityMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 17, 2025
Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study.

Zhongyi Xu, Yijie Xuan, Zhe Zhu

|Sep 06, 2025
Treatment of Acquired Dermal Macular Hyperpigmentation With Oral Isotretinoin: A Multi-Institutional Retrospective Study of 121 Cases.

Zhongyi Xu, Yuecen Ding, Chengfeng Zhang

|Jan 09, 2025
A rare severe acrodermatitis continua of Hallopeau treated with spesolimab.

Chenggong Guan, Zhongyi Xu, Yan Wang

|Jul 03, 2024
Correction: Dysfunction of ATG7-dependent autophagy dysregulates the antioxidant response and contributes to oxidative stress-induced biological impairments in human epidermal melanocytes.

Zhuhui Qiao, Zhongyi Xu, Qing Xiao

|Jun 10, 2024
Oral tofacitinib, baricitinib and upadacitinib monotherapy for steroid-resistant vitiligo: A prospective case series.

Yijian Zhu, Zhengzhou Shi, Zhongyi Xu

|Mar 08, 2024
Efficacy and safety of the combination of oral tranexamic acid and intense pulsed light versus oral tranexamic acid alone in the treatment of refractory Riehl's melanosis: A prospective, comparative study.

Zhongyi Xu, Chen Wang, Xiaoxue Xing

Pageof 3

Frequent Collaborators

12 joint publications

Chengfeng Zhang

7 joint publications

Leihong Xiang

5 joint publications

Xiaoxue Xing

3 joint publications

Jie Shen